Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Diplomat Pharmacy, Inc.DPLO · Entity 151818 | Director | October 01, 2018 | October 03, 2018 |
| P3 Health Partners Inc.PIII · Entity 4562 | Director | August 06, 2025 | January 23, 2026 |
| Progyny, Inc.PGNY · Entity 4521 | Director | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Diplomat Pharmacy, Inc.
Report date October 01, 2018 · Filed October 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,682 |
Reported balance
After 2018-10-01 transaction · row 1
1 source rowRow 1 · 2018-10-01 · Grant · Acquired 2,275 · Balance 45,682 F1: The shares of restricted stock were granted in connection with the Issuer's revised non-employee director compensation program, effective October 1, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of restricted stock were granted in connection with the Issuer's revised non-employee director compensation program, effective October 1, 2018.
P3 Health Partners Inc.
Report date August 06, 2025 · Filed January 23, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 6,331 |
Reported balance
After 2025-08-06 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2025-08-06 · Grant · Acquired 2,000 · Balance 6,331 F1: Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest upon the earlier of the Company's 2026 annual stockholder meeting and the one-year anniversary of the grant date. F2: This amended Form 4 is being filed to correct Column 5 of Table I, which inadvertently reported the number of securities beneficially owned by the Reporting Person prior to the Company's 1-for-50 reverse stock split, which became effective on April 11, 2025. This amended Form 4 is being filed solely to correct the number of securities beneficially owned by the Reporting Person following the reverse stock split. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest upon the earlier of the Company's 2026 annual stockholder meeting and the one-year anniversary of the grant date.
F2: This amended Form 4 is being filed to correct Column 5 of Table I, which inadvertently reported the number of securities beneficially owned by the Reporting Person prior to the Company's 1-for-50 reverse stock split, which became effective on April 11, 2025. This amended Form 4 is being filed solely to correct the number of securities beneficially owned by the Reporting Person following the reverse stock split.
Progyny, Inc.
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 39,981 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 7,924 · Balance 39,981 F1: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.69 · Expires 2036-05-20 | Direct | 5,205 |
Reported balance
After 2026-05-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-21 · Grant · Acquired 5,205 · Balance 5,205 F2: The option was issued to the Reporting Person in lieu of an annual cash retainer of $64,985 for board and committee service. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.69 · Expires 2036-05-20 | Direct | 31,458 |
Reported balance
After 2026-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-21 · Grant · Acquired 31,458 · Balance 31,458 F3: The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.
F2: The option was issued to the Reporting Person in lieu of an annual cash retainer of $64,985 for board and committee service. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.
F3: The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 26, 2026 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 31,458 | $0.00 Strike: $24.69 | $0.00 |
DisclosureSEC source: 0001551306-26-000099 · wk-form4_1779826941.xml · derivative · entry 3 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,458 Underlying: Common Stock · 31,458 shares Expires 2036-05-20 F3 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 5,205 | $12.49 Strike: $24.69 | $65,010.45 |
DisclosureSEC source: 0001551306-26-000099 · wk-form4_1779826941.xml · derivative · entry 2 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,205 Underlying: Common Stock · 5,205 shares Expires 2036-05-20 F2 · price: The option was issued to the Reporting Person in lieu of an annual cash retainer of $64,985 for board and committee service. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. F2 · derivative.exercise_date: The option was issued to the Reporting Person in lieu of an annual cash retainer of $64,985 for board and committee service. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 7,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001551306-26-000099 · wk-form4_1779826941.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,981 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 23:08 UTC | P3 Health Partners Inc. PIII · Entity 4562 | GrantClass A Common Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039351 · wk-form4_1754694514.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,561 F1 · shares: Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest in one year from date of grant. Read SEC document |
| August 06, 2025 Filed Jan 23, 2026 23:06 UTC Amendment | P3 Health Partners Inc. PIII · Entity 4562 | GrantClass A Common Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001406618-26-000003 · wk-form4a_1769209557.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,331 F1 · shares: Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest upon the earlier of the Company's 2026 annual stockholder meeting and the one-year anniversary of the grant date. F2 · balance_after: This amended Form 4 is being filed to correct Column 5 of Table I, which inadvertently reported the number of securities beneficially owned by the Reporting Person prior to the Company's 1-for-50 reverse stock split, which became effective on April 11, 2025. This amended Form 4 is being filed solely to correct the number of securities beneficially owned by the Reporting Person following the reverse stock split. Read SEC document |
| May 22, 2025 Filed May 28, 2025 01:54 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 35,265 | $0.00 Strike: $20.89 | $0.00 |
DisclosureSEC source: 0001551306-25-000120 · wk-form4_1748397244.xml · derivative · entry 3 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,265 Underlying: Common Stock · 35,265 shares Expires 2035-05-21 F3 · derivative.exercise_date: The shares subject to the option will vest on May 22, 2026, subject to the Reporting Person's continued service on such date. Read SEC document |
| May 22, 2025 Filed May 28, 2025 01:54 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 5,835 | $11.14 Strike: $20.89 | $65,001.90 |
DisclosureSEC source: 0001551306-25-000120 · wk-form4_1748397244.xml · derivative · entry 2 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,835 Underlying: Common Stock · 5,835 shares Expires 2035-05-21 F2 · derivative.exercise_date: The option was issued to the Reporting Person in lieu of an annual cash retainer of $65,000 for board and committee service. The shares subject to the option will vest on May 22, 2026, subject to the Reporting Person's continued service on such date. Read SEC document |
| May 22, 2025 Filed May 28, 2025 01:54 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 9,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001551306-25-000120 · wk-form4_1748397244.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,057 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on May 22, 2026, subject to the Reporting Person's continued service on such date. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 21:41 UTC | P3 Health Partners Inc. PIII · Entity 4562 | GrantStock Option (Right to Buy) · Derivative | 482,640 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001628280-24-027575 · wk-form4_1718055664.xml · derivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 482,640 Underlying: Class A Common Stock · 482,640 shares Expires 2034-06-06 F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 6, 2025 and (ii) the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| May 23, 2024 Filed May 29, 2024 01:38 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 25,997 | $0.00 Strike: $27.15 | $0.00 |
DisclosureSEC source: 0001551306-24-000114 · wk-form4_1716946720.xml · derivative · entry 2 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,997 Underlying: Common Stock · 25,997 shares Expires 2034-05-22 F2 · derivative.exercise_date: The shares subject to the option will vest on May 23, 2025, subject to the Reporting Person's continued service on such date. Read SEC document |
| May 23, 2024 Filed May 29, 2024 01:38 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 6,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001551306-24-000114 · wk-form4_1716946720.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,693 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on May 23, 2025, subject to the Reporting Person's continued service on such date. Read SEC document |
| October 23, 2023 Filed Jan 25, 2024 21:14 UTC | P3 Health Partners Inc. PIII · Entity 4562 | GrantClass A Common Stock | 216,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-002232 · wk-form4_1706217236.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,561 F1 · shares: Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest in two substantially equal installments on each of October 23, 2024 and October 23, 2025. Read SEC document |
| May 24, 2023 Filed May 26, 2023 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 19,029 | $0.00 Strike: $38.24 | $0.00 |
DisclosureSEC source: 0001628280-23-019979 · wf-form4_168513513746921.xml · derivative · entry 2 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,029 Underlying: Common Stock · 19,029 shares Expires 2033-05-23 F2 · derivative.exercise_date: The shares subject to the Option shall vest on May 24, 2024, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| May 24, 2023 Filed May 26, 2023 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 4,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019979 · wf-form4_168513513746921.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,517 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on May 24, 2024, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 21:02 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 1,752 | $0.00 Strike: $38.22 | $0.00 |
DisclosureSEC source: 0001628280-22-027087 · wf-form4_166681810023872.xml · derivative · entry 3 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,752 Underlying: Common Stock · 1,752 shares Expires 2032-10-23 F3 · price: This option was issued to the Reporting Person in lieu of annual retainers for board and committee service. The shares underlying the option reflect the payment in full of the Reporting Person's annual retainers of $34,845.84. F2 · derivative.exercise_date: The shares subject to the Option shall vest on May 23, 2023, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 21:02 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 16,240 | $0.00 Strike: $38.22 | $0.00 |
DisclosureSEC source: 0001628280-22-027087 · wf-form4_166681810023872.xml · derivative · entry 2 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,240 Underlying: Common Stock · 16,240 shares Expires 2032-10-23 F2 · derivative.exercise_date: The shares subject to the Option shall vest on May 23, 2023, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 21:02 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 3,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-027087 · wf-form4_166681810023872.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,132 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on May 23, 2023, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 21:06 UTC | P3 Health Partners Inc. PIII · Entity 4562 | GrantStock Option (Right to Buy) · Derivative | 85,535 | $0.00 Strike: $7.95 | $0.00 |
DisclosureSEC source: 0001104659-22-038844 · tm2210604-3_4seq1.xml · derivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,535 Underlying: Class A Common Stock · 85,535 shares Expires 2032-03-24 F1 · derivative.exercise_date: The option vests and becomes exercisable with respect to 50% of the shares on each of March 24, 2023 and March 24, 2024. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (right to buy) · Derivative | 2,596 | $0.00 Strike: $63.21 | $0.00 |
DisclosureSEC source: 0001179110-21-009628 · edgar.xml · derivative · entry 3 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,596 Underlying: Common Stock · 2,596 shares Expires 2026-10-23 F3 · price: This option was issued to the Reporting Person in lieu of annual retainers for board and committee chair service. The shares underlying the option reflect the payment in full of the Reporting Person's annual retainers of $60,000. F2 · derivative.exercise_date: The shares subject to the Option shall vest on October 24, 2022, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (right to buy) · Derivative | 16,417 | $0.00 Strike: $63.21 | $0.00 |
DisclosureSEC source: 0001179110-21-009628 · edgar.xml · derivative · entry 2 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,417 Underlying: Common Stock · 16,417 shares Expires 2026-10-23 F2 · derivative.exercise_date: The shares subject to the Option shall vest on October 24, 2022, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 2,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-009628 · edgar.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,652 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on October 24, 2022, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2020 Filed Oct 27, 2020 21:54 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (right to buy) · Derivative | 2,146 | $27.95 Strike: $27.95 | $59,980.70 |
DisclosureSEC source: 0001209191-20-055956 · doc4.xml · derivative · entry 3 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,146 Underlying: Common Stock · 2,146 shares Expires 2030-10-23 F3 · price: This option was issued to the Reporting Person in lieu of annual retainers for board and committee chair service. The shares underlying the option reflect the payment in full of the Reporting Person's annual retainers of $60,000. F2 · derivative.exercise_date: The shares subject to the Option shall vest on October 24, 2021, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2020 Filed Oct 27, 2020 21:54 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (right to buy) · Derivative | 28,000 | $0.00 Strike: $27.95 | $0.00 |
DisclosureSEC source: 0001209191-20-055956 · doc4.xml · derivative · entry 2 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2030-10-23 F2 · derivative.exercise_date: The shares subject to the Option shall vest on October 24, 2021, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2020 Filed Oct 27, 2020 21:54 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-055956 · doc4.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on October 24, 2021, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2020 Filed Nov 20, 2020 21:47 UTC Amendment | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (right to buy) · Derivative | 4,430 | $0.00 Strike: $27.95 | $0.00 |
DisclosureSEC source: 0001209191-20-059681 · doc4a.xml · derivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,430 Underlying: Common Stock · 4,430 shares Expires 2030-10-23 F1 · shares: This amendment to the Form 4 filed on October 27, 2020 corrects the number shares underlying the Option that was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of payment in full of the Reporting Person's annual retainers for board and committee chair service of $60,000. F2 · derivative.exercise_date: The shares subject to the Option shall vest on October 24, 2021, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 01:49 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (right to buy) · Derivative | 50,600 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0001209191-19-054019 · doc4.xml · derivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,600 Underlying: Common Stock · 50,600 shares Expires 2029-10-11 F1 · derivative.exercise_date: 17,600 shares subject to the Option shall vest on October 24, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:26 UTC | Diplomat Pharmacy, Inc. DPLO · Entity 151818 | GrantCommon Stock | 2,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-18-000095 · primary_doc.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,682 F1 · shares: The shares of restricted stock were granted in connection with the Issuer's revised non-employee director compensation program, effective October 1, 2018. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:13 UTC | Diplomat Pharmacy, Inc. DPLO · Entity 151818 | SaleCommon Stock | 1,695 | $25.26 | $42,807.73 |
DisclosureSEC source: 0001596771-18-000079 · primary_doc.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,407 F1 · kind: The sales reported in this Form 4 represent shares sold to cover the tax liability incurred incident to the vesting of previously granted restricted stock. F1 · shares: The sales reported in this Form 4 represent shares sold to cover the tax liability incurred incident to the vesting of previously granted restricted stock. F2 · price: The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $25.25 to $25.2601. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 20:36 UTC | Diplomat Pharmacy, Inc. DPLO · Entity 151818 | GrantCommon Stock | 3,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-18-000069 · primary_doc.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,102 F1 · shares: The shares of restricted stock were granted in connection with the Issuer's non-employee director compensation program. Read SEC document |
| May 23, 2018 Filed May 25, 2018 20:56 UTC | Diplomat Pharmacy, Inc. DPLO · Entity 151818 | SaleCommon Stock | 13,875 | $24.20 | $335,805.53 |
DisclosureSEC source: 0001406618-18-000003 · primary_doc.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,448 F1 · kind: (1) The sales reported in this Form 4 represent shares sold to cover the tax liability incurred incident to the delivery of shares of common stock from previously awarded Restricted Stock Units. F1 · shares: (1) The sales reported in this Form 4 represent shares sold to cover the tax liability incurred incident to the delivery of shares of common stock from previously awarded Restricted Stock Units. F2 · price: (2) The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $24.025 to $24.29 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: (3) Number of securities in this column gives effect to the forfeiture of 21,666 shares underlying RSUs since the reporting persons most recent filing, as certain vesting conditions were not met. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 21:16 UTC | Diplomat Pharmacy, Inc. DPLO · Entity 151818 | GrantCommon Stock | 69,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-18-000024 · primary_doc.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,989 F1 · balance_after: On January 4, 2018, the reporting person received a grant of restricted stock with a total value of $1,000,000 (approximately 48,146 shares of restricted stock based on the Company's closing stock price on the NYSE on the grant date) vesting in four equal installments. In connection with the Board's refinement of the reporting person's compensation package as Interim CEO, the reporting person's foregoing grant of restricted stock was subsequently cancelled on February 26, 2018. In lieu of the prior award, the reporting person received a grant of 69,349 restricted stock units ("RSUs") on February 26, 2018. 9,166 of these RSUs vested on the grant date and 60,183 of these RSUs will vest in five equal monthly installments on the fourth day of each month between March and July 2018. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:00 UTC | Diplomat Pharmacy, Inc. DPLO · Entity 151818 | GrantCommon Stock | 48,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001406618-18-000001 · primary_doc.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,786 F1 · shares: On January 4, 2018, the reporting person received a grant of restricted stock with a total value of $1,000,000, with such award to vest pro rata in four equal installments on March 31, June 30, September 30 and December 31, 2018, with the number of common shares to be received as of each vesting date based on the Company's closing common stock price on the NYSE as of such vesting date, or the Company's closing common stock price on the NYSE as of the business day immediately preceding such vesting date, in the event the vesting date is not a business day. The share amounts reported in columns 4 and 5 represent the estimated number of shares to be issued based on the Company's closing common stock price on the NYSE as of the grant date. F1 · balance_after: On January 4, 2018, the reporting person received a grant of restricted stock with a total value of $1,000,000, with such award to vest pro rata in four equal installments on March 31, June 30, September 30 and December 31, 2018, with the number of common shares to be received as of each vesting date based on the Company's closing common stock price on the NYSE as of such vesting date, or the Company's closing common stock price on the NYSE as of the business day immediately preceding such vesting date, in the event the vesting date is not a business day. The share amounts reported in columns 4 and 5 represent the estimated number of shares to be issued based on the Company's closing common stock price on the NYSE as of the grant date. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 15:56 UTC | Diplomat Pharmacy, Inc. DPLO · Entity 151818 | PurchaseCommon Stock | 3,000 | $15.46 | $46,392.60 |
DisclosureSEC source: 0001596771-17-000086 · primary_doc.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,640 Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 20:26 UTC | Diplomat Pharmacy, Inc. DPLO · Entity 151818 | GrantCommon Stock | 4,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-17-000057 · primary_doc.xml · nonDerivative · entry 1 Park Jeffrey G · CIK 0001406618 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,640 F1 · shares: The shares of restricted stock were granted in connection with the Issuer's non-employee director compensation program. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.